The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.
Anne Luise H VollesenAgneta SnoerBasit ChaudhryAnja Sofie PetersenAndreas HagedornJan HoffmannRigmor H JensenMessoud AshinaPublished in: Cephalalgia : an international journal of headache (2020)
Contrary to our hypothesis, attack induction was lower than expected and roughly equal by PACAP38 and vasoactive intestinal peptide in episodic active phase and chronic cluster headache patients, which contradicts the PAC1-receptor as being solely responsible for attack induction.Trial registration: clinicaltrials.gov (identifier NCT03814226).